| scholarly article | Q13442814 |
| P50 | author | Kah-Whye Peng | Q88612764 |
| P2093 | author name string | Ying Liu | |
| Thilo Stehle | |||
| Andrew Baker | |||
| André Lieber | |||
| Hongjie Wang | |||
| Steve Roffler | |||
| Daniel Stone | |||
| Zongyi Li | |||
| Sebastian Tuve | |||
| John McVey | |||
| Dmitry Shayakhmetov | |||
| Christophe L M Verlinde | |||
| Oleksandr Kalyushniy | |||
| P2860 | cites work | Adenovirus Binding to Blood Factors Results in Liver Cell Infection and Hepatotoxicity | Q27469833 |
| Adenovirus type 11 binding alters the conformation of its receptor CD46 | Q27643524 | ||
| Identification of CD46 Binding Sites within the Adenovirus Serotype 35 Fiber Knob | Q27648583 | ||
| Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library | Q32060783 | ||
| Efficient gene transfer into human CD34(+) cells by a retargeted adenovirus vector | Q33799667 | ||
| The distal short consensus repeats 1 and 2 of the membrane cofactor protein CD46 and their distance from the cell membrane determine productive entry of species B adenovirus serotype 35 | Q33908780 | ||
| Evaluation of adenovirus vectors containing serotype 35 fibers for vaccination | Q34507185 | ||
| Avidin-based targeting and purification of a protein IX-modified, metabolically biotinylated adenoviral vector. | Q35019399 | ||
| Affinity thresholds for membrane fusion triggering by viral glycoproteins | Q36315685 | ||
| Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivo | Q36535456 | ||
| New serotypes of adenoviral vectors | Q36641334 | ||
| Engineering targeted viral vectors for gene therapy | Q36868494 | ||
| Intracellular trafficking of adenovirus: many means to many ends | Q36913904 | ||
| Complex target SELEX. | Q37056570 | ||
| Lack of high affinity fiber receptor activity explains the resistance of ciliated airway epithelia to adenovirus infection | Q37371791 | ||
| Dependence of adenovirus infectivity on length of the fiber shaft domain | Q39585255 | ||
| Identification of contact residues and definition of the CAR-binding site of adenovirus type 5 fiber protein | Q39589919 | ||
| The interaction between the fiber knob domain and the cellular attachment receptor determines the intracellular trafficking route of adenoviruses | Q39732535 | ||
| Upregulation of integrins alpha v beta 3 and alpha v beta 5 on human monocytes and T lymphocytes facilitates adenovirus-mediated gene delivery | Q39869620 | ||
| Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli. | Q39875310 | ||
| Transgenic mice expressing human measles virus (MV) receptor CD46 provide cells exhibiting different permissivities to MV infections. | Q39876381 | ||
| Genome size and structure determine efficiency of postinternalization steps and gene transfer of capsid-modified adenovirus vectors in a cell-type-specific manner | Q39960246 | ||
| A ligand-pseudoreceptor system based on de novo designed peptides for the generation of adenoviral vectors with altered tropism. | Q40026203 | ||
| Modification of adenovirus capsid with a designed protein ligand yields a gene vector targeted to a major molecular marker of cancer | Q40055106 | ||
| Interaction of penton base Arg-Gly-Asp motifs with integrins is crucial for adenovirus serotype 35 vector transduction in human hematopoietic cells | Q40084250 | ||
| Downregulation of human CD46 by adenovirus serotype 35 vectors | Q40155682 | ||
| A new group B adenovirus receptor is expressed at high levels on human stem and tumor cells. | Q40223632 | ||
| Evaluation of adenovirus vectors containing serotype 35 fibers for tumor targeting | Q40250421 | ||
| Adenovirus type 5 interactions with human blood cells may compromise systemic delivery. | Q40297306 | ||
| Localization of regions in CD46 that interact with adenovirus | Q40416477 | ||
| High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virus | Q40534840 | ||
| Deletion of penton RGD motifs affects the efficiency of both the internalization and the endosome escape of viral particles containing adenovirus serotype 5 or 35 fiber knobs | Q40722127 | ||
| Adenovirus-platelet interaction in blood causes virus sequestration to the reticuloendothelial system of the liver | Q41786777 | ||
| Abrupt emergence of diverse species B adenoviruses at US military recruit training centers | Q43663175 | ||
| Linking innate and acquired immunity: divergent role of CD46 cytoplasmic domains in T cell induced inflammation | Q44021757 | ||
| CD46 is a cellular receptor for group B adenoviruses | Q45869560 | ||
| Adenovirus serotype 5 hexon mediates liver gene transfer | Q45875068 | ||
| Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration. | Q45880303 | ||
| Transduction properties of adenovirus serotype 35 vectors after intravenous administration into nonhuman primates | Q64376738 | ||
| Sustained AAV-mediated dystrophin expression in a canine model of Duchenne muscular dystrophy with a brief course of immunosuppression | Q80141652 | ||
| P433 | issue | 21 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Adenoviridae | Q193447 |
| P304 | page(s) | 10567-10579 | |
| P577 | publication date | 2008-08-27 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | In vitro and in vivo properties of adenovirus vectors with increased affinity to CD46 | |
| P478 | volume | 82 |
| Q47162946 | A Combined In Vivo HSC Transduction/Selection Approach Results in Efficient and Stable Gene Expression in Peripheral Blood Cells in Mice |
| Q49963933 | A novel fiber chimeric conditionally replicative adenovirus-Ad5/F35 for tumor therapy |
| Q30959165 | A recombinant adenovirus type 35 fiber knob protein sensitizes lymphoma cells to rituximab therapy |
| Q64374953 | Adenovirus interactions with CD46 on transgenic mouse erythrocytes |
| Q43655746 | Attenuation of CD4+ T-cell function by human adenovirus type 35 is mediated by the knob protein |
| Q35689715 | Avidity binding of human adenovirus serotypes 3 and 7 to the membrane cofactor CD46 triggers infection |
| Q34282191 | Biodistribution and retargeting of FX-binding ablated adenovirus serotype 5 vectors |
| Q47236016 | Cell and Gene Therapy for HIV Cure |
| Q39236963 | Chimeric 5/35 adenovirus-mediated Dickkopf-1 overexpression suppressed tumorigenicity of CD44⁺ gastric cancer cells via attenuating Wnt signaling. |
| Q34781681 | Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14. |
| Q34120794 | Development of a targeted gene vector platform based on simian adenovirus serotype 24. |
| Q45886050 | Development of fiber-substituted adenovirus vectors containing foreign peptides in the adenovirus serotype 35 fiber knob |
| Q37100291 | Evaluation of CD46 re-targeted adenoviral vectors for clinical ovarian cancer intraperitoneal therapy |
| Q64376811 | HDAd5/35 Adenovirus Vector Expressing Anti-CRISPR Peptides Decreases CRISPR/Cas9 Toxicity in Human Hematopoietic Stem Cells |
| Q33740415 | Her2-specific multivalent adapters confer designed tropism to adenovirus for gene targeting |
| Q39553529 | High Efficiency Ex Vivo Gene Transfer to Primary Murine B Cells Using Plasmid or Viral Vectors |
| Q90493905 | High-level protein production in erythroid cells derived from in vivo transduced hematopoietic stem cells |
| Q64914676 | In vivo hematopoietic stem cell gene therapy ameliorates murine thalassemia intermedia. |
| Q37394036 | In vivo transduction of primitive mobilized hematopoietic stem cells after intravenous injection of integrating adenovirus vectors |
| Q39502394 | Influence of coagulation factor x on in vitro and in vivo gene delivery by adenovirus (Ad) 5, Ad35, and chimeric Ad5/Ad35 vectors |
| Q55333613 | Integrating HDAd5/35++ Vectors as a New Platform for HSC Gene Therapy of Hemoglobinopathies. |
| Q40045829 | In Vivo Hematopoietic Stem Cell Transduction. |
| Q37984486 | Manipulation of adenovirus interactions with host factors for gene therapy applications |
| Q36744857 | Preclinical safety, pharmacokinetics, pharmacodynamics, and biodistribution studies with Ad35K++ protein: a novel rituximab cotherapeutic |
| Q38163242 | Protein engineering to target complement evasion in cancer |
| Q41765546 | Pseudotyping the adenovirus serotype 5 capsid with both the fibre and penton of serotype 35 enhances vascular smooth muscle cell transduction. |
| Q46750116 | Recombinant Ad35 adenoviral proteins as potent modulators of human T cell activation |
| Q42208596 | Retinal transduction profiles by high-capacity viral vectors |
| Q93169160 | Targeted Integration and High-Level Transgene Expression in AAVS1 Transgenic Mice after In Vivo HSC Transduction with HDAd5/35++ Vectors |
| Q52584334 | Targeting oncogenic Ras by the Clostridium perfringens toxin TpeL. |
| Q42139355 | The Reorientation of T-Cell Polarity and Inhibition of Immunological Synapse Formation by CD46 Involves Its Recruitment to Lipid Rafts. |
| Q38230901 | The importance of coagulation factors binding to adenovirus: historical perspectives and implications for gene delivery |
| Q36673736 | Transient removal of CD46 is safe and increases B-cell depletion by rituximab in CD46 transgenic mice and macaques |
| Q38614156 | Tropism-modification strategies for targeted gene delivery using adenoviral vectors |
Search more.